Plus Therapeutics Grants Stock Options and RSUs to New CNSide Diagnostics Hires
I'm PortAI, I can summarize articles.
Plus Therapeutics Inc. has granted stock options and RSUs to new hires at its CNSide Diagnostics subsidiary. Mr. Gurnani and Ms. Luckey received options to purchase 33,750 shares each, vesting over four years. This announcement was made via GlobeNewswire on December 09, 2025, and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments